Analysis Finds That Medications for Hepatitis C, HIV/AIDS are Costliest Group of Outpatient Prescription Drugs for Medicaid
February 15, 2019
February 15, 2019
WASHINGTON, Feb. 15 -- The Henry J. Kaiser Family Foundation issued the following news release:
* * *
- While Diabetes Drugs Have Posted Sharpest Rise in Costs
* * *
Antiviral medications, including those that treat hepatitis C and HIV/AIDS, cost the Medicaid program more money (before rebates) than any other group of outpatient prescription drugs for each year from 2014 to 2017, according to a new KFF analysis.
The analysis of uti . . .
* * *
- While Diabetes Drugs Have Posted Sharpest Rise in Costs
* * *
Antiviral medications, including those that treat hepatitis C and HIV/AIDS, cost the Medicaid program more money (before rebates) than any other group of outpatient prescription drugs for each year from 2014 to 2017, according to a new KFF analysis.
The analysis of uti . . .